{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T09:15:28Z","timestamp":1788081328000,"version":"build-2784847793"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T00:00:00Z","timestamp":1785283200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioactive Materials"],"published-print":{"date-parts":[[2027,1]]},"DOI":"10.1016\/j.bioactmat.2026.07.054","type":"journal-article","created":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T14:38:30Z","timestamp":1785854310000},"page":"127-142","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["LDH-mediated autophagic full-chain blockade for Multiple Myeloma treatment by targeting circ_0008255\/miR-192-5p\/ATG2A axis"],"prefix":"10.1016","volume":"67","author":[{"given":"Zhenhua","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hefei","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongkun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jieyun","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiafeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaochao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liuzhi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fenyong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yelin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7836-7345","authenticated-orcid":false,"given":"Lin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioactmat.2026.07.054_bib1","doi-asserted-by":"crossref","DOI":"10.1038\/s41408-022-00643-3","article-title":"Extramedullary disease in multiple myeloma: a systematic literature review","author":"Blad\u00e9","year":"2022","journal-title":"Blood Cancer J."},{"issue":"1","key":"10.1016\/j.bioactmat.2026.07.054_bib2","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41572-024-00529-7","article-title":"Multiple myeloma","volume":"10","author":"Malard","year":"2024","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"2","key":"10.1016\/j.bioactmat.2026.07.054_bib3","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.hoc.2023.12.008","article-title":"Approach to high-risk multiple myeloma","volume":"38","author":"Chen","year":"2024","journal-title":"Hematol. Oncol. Clin. N. Am."},{"key":"10.1016\/j.bioactmat.2026.07.054_bib4","doi-asserted-by":"crossref","DOI":"10.1038\/s41571-021-00585-y","article-title":"The emerging roles of circRNAs in cancer and oncology","author":"Kristensen","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.bioactmat.2026.07.054_bib5","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s12943-022-01582-0","article-title":"The functional roles of the circRNA\/Wnt axis in cancer","volume":"21","author":"Xue","year":"2022","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bioactmat.2026.07.054_bib6","article-title":"Circular RNAs: characterization cellular roles, and applications (vol 185, pg 2016","author":"Liu","year":"2022","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.bioactmat.2026.07.054_bib7","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.3390\/cancers14071700","article-title":"Circular RNA as a novel biomarker for diagnosis and prognosis and potential therapeutic targets in multiple myeloma","volume":"14","author":"Allegra","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bioactmat.2026.07.054_bib8","doi-asserted-by":"crossref","DOI":"10.1038\/s41580-023-00585-z","article-title":"Autophagy and autophagy-related pathways in cancer","author":"Debnath","year":"2023","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"3","key":"10.1016\/j.bioactmat.2026.07.054_bib9","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1080\/15548627.2021.1936359","article-title":"Targeting autophagy in disease: established and new strategies","volume":"18","author":"Kocak","year":"2022","journal-title":"Autophagy"},{"key":"10.1016\/j.bioactmat.2026.07.054_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2023.108485","article-title":"Autophagy inhibitors for cancer therapy: small molecules and nanomedicines","volume":"249","author":"Chen","year":"2023","journal-title":"Pharmacol. Ther."},{"issue":"613","key":"10.1016\/j.bioactmat.2026.07.054_bib11","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abd5016","article-title":"ULK1 inhibition promotes oxidative stress-induced differentiation and sensitizes leukemic stem cells to targeted therapy","volume":"13","author":"Ianniciello","year":"2021","journal-title":"Sci. Transl. Med."},{"issue":"2","key":"10.1016\/j.bioactmat.2026.07.054_bib12","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24020953","article-title":"Small molecule inhibitors for Unc-51-like autophagy-activating kinase targeting autophagy in cancer","volume":"24","author":"Karmacharya","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioactmat.2026.07.054_bib13","article-title":"Enhanced blood-brain barrier penetrability of BACE1 SiRNA-Loaded prussian blue nanocomplexes for Alzheimer's Disease synergy therapy","volume":"5","author":"Ding","year":"2025","journal-title":"Exploration (Beijing)"},{"issue":"12","key":"10.1016\/j.bioactmat.2026.07.054_bib14","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1016\/j.cell.2022.04.021","article-title":"Circular RNAs: characterization, cellular roles, and applications","volume":"185","author":"Liu","year":"2022","journal-title":"Cell."},{"issue":"3","key":"10.1016\/j.bioactmat.2026.07.054_bib15","doi-asserted-by":"crossref","first-page":"279","DOI":"10.4161\/auto.7.3.14487","article-title":"Selective autophagy mediated by autophagic adapter proteins","volume":"7","author":"Johansen","year":"2011","journal-title":"Autophagy"},{"issue":"5","key":"10.1016\/j.bioactmat.2026.07.054_bib16","first-page":"5343","article-title":"Expression level of miRNA in the peripheral blood of patients with multiple myeloma and its clinical significance","volume":"13","author":"Li","year":"2021","journal-title":"Am. J. Transl. Res."},{"issue":"22","key":"10.1016\/j.bioactmat.2026.07.054_bib17","doi-asserted-by":"crossref","first-page":"4324","DOI":"10.1016\/j.molcel.2022.10.017","article-title":"ATG9A and ATG2A form a heteromeric complex essential for autophagosome formation","volume":"82","author":"van Vliet","year":"2022","journal-title":"Mol Cell"},{"key":"10.1016\/j.bioactmat.2026.07.054_bib18","article-title":"Tumor cell membrane-based vaccines: a potential boost for cancer immunotherapy","volume":"4","author":"Yang","year":"2024","journal-title":"Exploration (Beijing)"},{"key":"10.1016\/j.bioactmat.2026.07.054_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.copbio.2024.103128","article-title":"Does the surface charge of the nanoparticles drive nanoparticle-cell membrane interactions","volume":"87","author":"Balog","year":"2024","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/j.bioactmat.2026.07.054_bib20","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jconrel.2022.05.043","article-title":"Circular RNA: an emerging frontier in RNA therapeutic targets, RNA therapeutics, and mRNA vaccines","volume":"348","author":"Liu","year":"2022","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.bioactmat.2026.07.054_bib21","doi-asserted-by":"crossref","DOI":"10.1080\/15548627.2021.1917131","article-title":"The influence of circular RNAs on autophagy and disease progression","author":"Wang","year":"2022","journal-title":"Autophagy"},{"issue":"1","key":"10.1016\/j.bioactmat.2026.07.054_bib22","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1186\/s12935-021-02011-w","article-title":"Exosomal circRNA as a novel potential therapeutic target for multiple myeloma-related myocardial damage","volume":"21","author":"Sun","year":"2021","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.bioactmat.2026.07.054_bib23","article-title":"Inhibition of hsa_circ_0003489 shifts balance from autophagy to apoptosis and sensitizes multiple myeloma cells to Bortezomib via miR4\/HDAC1 axis","author":"Tian Fi","year":"2021","journal-title":"J. Gene Med."},{"issue":"1","key":"10.1016\/j.bioactmat.2026.07.054_bib24","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1186\/s13018-021-02867-8","article-title":"Down-regulation of circ_0058058 suppresses proliferation, angiogenesis and metastasis in multiple myeloma through miR-338-3p\/ATG14 pathway","volume":"16","author":"Xue","year":"2021","journal-title":"J. Orthop. Surg. Res."},{"issue":"1\u20132","key":"10.1016\/j.bioactmat.2026.07.054_bib25","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.cell.2018.09.048","article-title":"Biological functions of autophagy genes: a disease perspective","volume":"176","author":"Levine","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.bioactmat.2026.07.054_bib26","doi-asserted-by":"crossref","DOI":"10.1080\/15548627.2019.1659622","article-title":"ATG2A transfers lipids between membranes in vitro","author":"Otomo","year":"2019","journal-title":"Autophagy"},{"key":"10.1016\/j.bioactmat.2026.07.054_bib27","doi-asserted-by":"crossref","DOI":"10.1038\/s41573-026-01449-9","article-title":"Autophagy modulation in cancer","author":"Guilbaud","year":"2026","journal-title":"Nat. Rev. Drug Discov."},{"issue":"4","key":"10.1016\/j.bioactmat.2026.07.054_bib28","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/s41571-021-00593-y","article-title":"Single-cell profiling of tumour evolution in multiple myeloma - opportunities for precision medicine","volume":"19","author":"Dutta","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.bioactmat.2026.07.054_bib29","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.jconrel.2021.04.034","volume":"334","author":"Sadat","year":"2021","journal-title":"J. Contr. Release"},{"issue":"1","key":"10.1016\/j.bioactmat.2026.07.054_bib30","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s12943-022-01575-z","article-title":"M6A-mediated upregulation of circMDK promotes tumorigenesis and acts as a nanotherapeutic target in hepatocellular carcinoma","volume":"21","author":"Du","year":"2022","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.bioactmat.2026.07.054_bib31","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s12943-025-02234-9","article-title":"Circular RNA circBNC2 inhibits tumorigenesis by modulating ferroptosis and acts as a nanotherapeutic target in prostate cancer","volume":"24","author":"Pan","year":"2025","journal-title":"Mol. Cancer"},{"issue":"21","key":"10.1016\/j.bioactmat.2026.07.054_bib32","doi-asserted-by":"crossref","first-page":"10523","DOI":"10.1039\/D4CS00339J","article-title":"Designed functions of oxide\/hydroxide nanosheets via elemental replacement\/doping","volume":"53","author":"Saito","year":"2024","journal-title":"Chem. Soc. Rev."},{"issue":"17","key":"10.1016\/j.bioactmat.2026.07.054_bib33","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202108653","article-title":"Blocking cancer-nerve crosstalk for treatment of metastatic bone cancer pain","volume":"34","author":"Chu","year":"2022","journal-title":"Adv Mater."},{"issue":"15","key":"10.1016\/j.bioactmat.2026.07.054_bib34","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26157301","article-title":"Breaking barriers: the role of the bone marrow microenvironment in multiple myeloma progression","volume":"26","author":"Agafonova","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"21","key":"10.1016\/j.bioactmat.2026.07.054_bib35","article-title":"Delivery of therapeutic RNA to the bone marrow in multiple myeloma using CD38-Targeted lipid nanoparticles","volume":"10","author":"Tarab-Ravski","year":"2023","journal-title":"Adv. Sci. (Weinh.)"},{"issue":"Sup1","key":"10.1016\/j.bioactmat.2026.07.054_bib36","doi-asserted-by":"crossref","first-page":"4332","DOI":"10.1182\/blood-2019-126617","article-title":"NEK2 promotes bortezomib resistance through enhancing autophagy by upregulation of Beclin1 in multiple myeloma cells","volume":"134","author":"Xia","year":"2019","journal-title":"Blood"}],"container-title":["Bioactive Materials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452199X26004512?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452199X26004512?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T08:56:51Z","timestamp":1788080211000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2452199X26004512"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,1]]},"references-count":36,"alternative-id":["S2452199X26004512"],"URL":"https:\/\/doi.org\/10.1016\/j.bioactmat.2026.07.054","relation":{},"ISSN":["2452-199X"],"issn-type":[{"value":"2452-199X","type":"print"}],"subject":[],"published":{"date-parts":[[2027,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"LDH-mediated autophagic full-chain blockade for Multiple Myeloma treatment by targeting circ_0008255\/miR-192-5p\/ATG2A axis","name":"articletitle","label":"Article Title"},{"value":"Bioactive Materials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioactmat.2026.07.054","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd.","name":"copyright","label":"Copyright"}]}}